Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
102.60    -0.60 (-0.58%)
Bid:
102.20
Ask:
102.80
Spread: 0.60 (0.587%)
Market Cap: £168.21m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Adrian Whitfield to step down as CEO

1 Jul 2014 07:00

RNS Number : 9651K
Synthomer PLC
01 July 2014
 



July 1st 2014

Adrian Whitfield to step down as Group Chief Executive in June 2015

Synthomer plc ('Synthomer' or the 'Company') today announces that Adrian Whitfield, Group Chief Executive, will step down after eight years with the Company. To allow sufficient time for a replacement to be found and an orderly transition to take place, Adrian will remain as Group Chief Executive and on the Board until 30 June 2015.

 

The Board will conduct a comprehensive search for the Company's next Chief Executive and a further announcement will be made in due course.

Neil Johnson, Chairman, said: "Over the past 8 years, Adrian has overseen Synthomer's transformation from a small, diversified chemical business to a world leading producer of aqueous polymers. He led the highly successful acquisition of PolymerLatex in 2011 and during his tenure the Company's revenues have more than doubled to over £1 billion.

 

Today the business has a robust balance sheet, strong cashflow and excellent management team. On behalf of the board, I would like to thank Adrian for his hard work and commitment. We are sorry to see him go and wish him all the best for the future."

Adrian Whitfield said:

 

"The 8 years that I have spent with Synthomer have been among the most rewarding of my career. I am proud of the significant turnaround that has been achieved and our track record of strong growth. I have been fortunate to work with a fantastic team and Synthomer's dedicated employees around the world.

 

With the business on a solid platform supported by a clear strategy for future growth, now is the right time in my career to step down and allow someone else to take Synthomer forward. While I remain completely focused on the job until my successor is in place, my thanks go to the Board and everyone at Synthomer for supporting me in leading the Company through such a successful period of its development."

 

 

Enquiries:

 

Synthomer plc

Neil Johnson, Chairman

 

Adrian Whitfield, Group Chief ExecutiveDavid Blackwood, Chief Financial Officer

 

 

 

 

+44 (0) 20 3603 5220 (c/o Pendomer)

 

+44 (0) 1279 442791

Pendomer CommunicationsCharles Armitstead

 

+44 (0) 20 3603 5224

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEASKEDAPLEFF
Date   Source Headline
1st Jun 20262:42 pmRNSHolding(s) in Company
29th May 20263:57 pmRNSTotal Voting Rights
22nd May 20265:21 pmRNSNotice of AGM
8th May 20264:33 pmRNSAdmission to Trading
7th May 20261:51 pmRNSApplication for Admission to Trading
5th May 20264:25 pmRNSHolding(s) in Company
30th Apr 20264:40 pmRNSAnnual Financial Report
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
30th Apr 202611:25 amRNSDirector/PDMR Shareholding
30th Apr 20267:01 amRNSChange of Chief Financial Officer
30th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSTrading and refinancing update
11th Feb 20261:46 pmRNSStatement re potential refinancing
29th Jan 20267:00 amRNSTrading Statement - Winter 2026
27th Jan 20264:51 pmRNSHolding(s) in Company
26th Jan 20264:23 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSReceivables purchasing arrangement
12th Dec 20259:30 amRNSDirectorate change
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20251:28 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSTrading statement - Autumn 2025
14th Oct 20257:00 amRNSAppointment of joint corporate broker
4th Sep 20255:17 pmRNSHolding(s) in Company
11th Aug 20258:00 amRNSDirector/PDMR Shareholding
6th Aug 20259:45 amRNSDirector/PDMR Shareholding
5th Aug 202511:57 amRNSDirector/PDMR Shareholding
5th Aug 202511:00 amRNSDirectorate Change
5th Aug 20257:00 amRNSInterim results
4th Jul 20257:01 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCovenant update
30th Jun 20257:00 amRNSDirectorate Changes
27th Jun 20254:21 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDivestment of William Blythe completed
6th May 20257:00 amRNSDivestment of William Blythe
1st May 20254:18 pmRNSResults of AGM
1st May 20257:00 amRNSTrading Statement - Spring 2025
15th Apr 20253:00 pmRNSHolding(s) in Company
28th Mar 20257:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:30 amRNSDirector/PDMR Shareholding
25th Mar 20254:23 pmRNSAnnual Report and Notice of AGM
25th Mar 202511:43 amRNSDirector/PDMR Shareholding
25th Mar 202511:41 amRNSDirector/PDMR Shareholding
24th Mar 20257:30 amRNSHolding(s) in Company
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSFinal Results
6th Mar 20258:32 amRNSDirector Declaration
13th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 202510:30 amRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSWinter trading statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.